litlas
Log inCreate account

Jonathan I. Silverberg

Active 1993–2025

Also published as
Jonathan I Silverberg
365
Papers
34,515
Citations
98
h-index
342
i10-index

Citations

Citations per year for Jonathan I. Silverberg1922: 1 citations1981: 1 citations1986: 2 citations1993: 1 citations1998: 1 citations1999: 2 citations2008: 1 citations2010: 1 citations2011: 32 citations2012: 4 citations2013: 24 citations2014: 36 citations2015: 72 citations2016: 87 citations2017: 240 citations2018: 294 citations2019: 1,166 citations2020: 1,582 citations2021: 2,105 citations2022: 1,653 citations2023: 1,836 citations2024: 2,578 citations2025: 1,536 citations2026: 15 citations1923–1980: no citations, so these years are not shown1982–1985: no citations, so these years are not shown1987–1992: no citations, so these years are not shown1994–1997: no citations, so these years are not shown2000–2007: no citations, so these years are not shown2009: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,321 citing papers, 21.8% of this breakdownGermany: 745 citing papers, 7% of this breakdownChina: 698 citing papers, 6.6% of this breakdownUnited Kingdom: 650 citing papers, 6.1% of this breakdownCanada: 479 citing papers, 4.5% of this breakdownItaly: 474 citing papers, 4.5% of this breakdownJapan: 431 citing papers, 4% of this breakdownFrance: 425 citing papers, 4% of this breakdownDenmark: 329 citing papers, 3.1% of this breakdownSpain: 312 citing papers, 2.9% of this breakdownNetherlands: 296 citing papers, 2.8% of this breakdownSwitzerland: 266 citing papers, 2.5% of this breakdown
0%21.8%Other 30.2%

Institutions

Fields

  • Medicine84.6%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology4.6%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Environmental Science1%
  • Neuroscience0.9%
  • Other2.6%

Topics

  • Dermatology and Skin Diseases21.2%
  • Allergic Rhinitis and Sensitization9.8%
  • Asthma and respiratory diseases7.7%
  • Psoriasis: Treatment and Pathogenesis6.3%
  • Food Allergy and Anaphylaxis Research4%
  • Urticaria and Related Conditions3.7%
  • Other47.3%

Coauthors

All papers

Open in search
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - New England Journal of Medicine 2016 cited by 2,045

  2. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

    Authors: Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, Mayte Suárez‐Fariñas, Marius Ardeleanu, Hitokazu Esaki, Maria Suprun, Yeriel Estrada, Hui Xu, Xiangyu Peng, Jonathan I. Silverberg, Alan Menter, James G. Krueger, Rick Zhang, Usman Chaudhry, Brian N. Swanson, Neil M.H. Graham, Gianluca Pirozzi, George D. Yancopoulos, Jennifer D. Hamilton - Journal of Allergy and Clinical Immunology 2018 cited by 678

  3. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

    Authors: Jonathan I. Silverberg, Emma Guttman‐Yassky, Diamant Thaçi, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia‐Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar Pillai, Julien Sénéschal - New England Journal of Medicine 2023 cited by 314

  4. Atopic dermatitis in the pediatric population

    Authors: Jonathan I. Silverberg, S. Barbarot, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, Grèce Saba, Isabelle Guillemin, Miriam C. Fenton, S. Auziere, Laurent Eckert - Annals of Allergy Asthma & Immunology 2021 cited by 445

  5. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations

    Authors: Derek K. Chu, Lynda C. Schneider, Rachel N. Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O’Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, Gordon Guyatt, Korey Capozza, Wendy Smith Begolka, A. Chu, Irene X. Zhao, Lina Chen, Paul Oykhman, Layla Bakaa, David B.K. Golden, Marcus Shaker, Jonathan A. Bernstein, Matthew Greenhawt, Caroline C. Horner, Phil Lieberman, David R. Stukus, Matthew A. Rank, Julie Wang, Anne K. Ellis, Elissa M. Abrams, Dennis K. Ledford, Derek K. Chu, Derek K. Chu, Derek K. Chu - Annals of Allergy Asthma & Immunology 2023 cited by 317

  6. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Thomas Werfel, Jiewei Zeng, Xiaohong Huang, Xiaofei Hu, Barbara A. Hendrickson, Barry Ladizinski, Alvina D. Chu, Jonathan I. Silverberg - The Lancet 2021 cited by 389

  7. Global Skin Disease Morbidity and Mortality

    Authors: Chanté Karimkhani, Robert P. Dellavalle, Luc E. Coffeng, Carsten Flohr, Roderick J. Hay, Sinéad Langan, Elaine O. Nsoesie, Alize J Ferrari, Holly E Erskine, Jonathan I. Silverberg, Theo Vos, Mohsen Naghavi - JAMA Dermatology 2017 cited by 719

  8. Patient burden and quality of life in atopic dermatitis in US adults

    Authors: Jonathan I. Silverberg, Joel M. Gelfand, David J. Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell H. Grayson, Eric L. Simpson, Peck Y. Ong, Zelma C. Chiesa Fuxench - Annals of Allergy Asthma & Immunology 2018 cited by 625

  9. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

    Authors: Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, C. Paul, Andrew Pink, Yoko Kataoka, Chia‐Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana A. Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernán Valdez - New England Journal of Medicine 2021 cited by 453

  10. Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

    Authors: Jonathan I. Silverberg, D. Toth, Thomas Bieber, Andrew Alexis, Boni E. Elewski, Andrew Pink, DirkJan Hijnen, T.N. Jensen, B K Bang, C.K. Olsen, Azra Kurbasic, Stephan Weidinger, the ECZTRA 3 study investigators - British Journal of Dermatology 2020 cited by 317

  11. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

    Authors: Zelma C. Chiesa Fuxench, Julie Block, Mark Boguniewicz, John Boyle, Luz Fonacier, Joel M. Gelfand, Mitchell H. Grayson, David J. Margolis, Lynda Mitchell, Jonathan I. Silverberg, Lawrence B. Schwartz, Eric L. Simpson, Peck Y. Ong - Journal of Investigative Dermatology 2018 cited by 408

  12. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection

    Authors: Anna Fishbein, Jonathan I. Silverberg, Eve J. Wilson, Peck Y. Ong - The Journal of Allergy and Clinical Immunology In Practice 2019 cited by 312

  13. Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

    Authors: Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Melinda Gooderham, Gary Chan, Claire Feeney, Pinaki Biswas, Hernán Valdez, Marco DiBonaventura, Chudy I. Nduaka, Ricardo Rojo - JAMA Dermatology 2020 cited by 388

  14. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

    Authors: Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Robert Sidbury - Journal of the American Academy of Dermatology 2023 cited by 215

  15. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis

    Authors: Harrison H. Lee, Eran C. Gwillim, Kevin R. Patel, Tammy Hua, Supriya Rastogi, Erin Ibler, Jonathan I. Silverberg - Journal of the American Academy of Dermatology 2019 cited by 331

  16. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

    Authors: Anne‐Sofie Halling, Nikolai Loft, Jonathan I. Silverberg, Emma Guttman‐Yassky, Jacob P. Thyssen - Journal of the American Academy of Dermatology 2020 cited by 278

  17. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials

    Authors: Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman‐Yassky, Thomas Bieber, E. Serra‐Baldrich, Eric L. Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther García Gil, Jonathan I. Silverberg - British Journal of Dermatology 2023 cited by 149

  18. Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

    Authors: Emma Guttman‐Yassky, Diamant Thaçi, Aileen L. Pangan, Hwanhee Hong, Kim Papp, Kristian Reich, Lisa A. Beck, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, J. Anderson, Yihua Gu, Henrique D. Teixeira, Jonathan I. Silverberg - Journal of Allergy and Clinical Immunology 2019 cited by 357

  19. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials

    Authors: A. Chu, Melanie Wong, Daniel Rayner, Gordon Guyatt, Juan Pablo Díaz Martinez, Renata Ceccacci, Irene X. Zhao, Eric McMullen, Archita Srivastava, Jason Wang, Aaron Wen, Fang Wang, Romina Brignardello‐Petersen, Ariel Izcovich, Paul Oykhman, Kathryn E. Wheeler, Julie Wang, Jonathan M. Spergel, Jasvinder A. Singh, Jonathan I. Silverberg, Peck Y. Ong, Monica O’Brien, Stephen A. Martin, Peter Lio, Mary Laura Lind, Jennifer LeBovidge, Elaine Kim, Joey Huynh, Matthew Greenhawt, Donna D. Gardner, Winfred Frazier, Kathy Ellison, Lina Chen, Korey Capozza, Anna De Benedetto, Mark Boguniewicz, Wendy Smith Begolka, Rachel N. Asiniwasis, Lynda C. Schneider, Derek K. Chu - Journal of Allergy and Clinical Immunology 2023 cited by 153

  20. Comorbidities and the impact of atopic dermatitis

    Authors: Jonathan I. Silverberg - Annals of Allergy Asthma & Immunology 2019 cited by 414

  21. Guidelines of care for the management of atopic dermatitis in adults with topical therapies

    Authors: Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Dawn Marie R. Davis - Journal of the American Academy of Dermatology 2023 cited by 182

  22. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

    Authors: Kristian Reich, Kenji Kabashima, Ketty Peris, Jonathan I. Silverberg, Lawrence F. Eichenfield, Thomas Bieber, Aleksandra Kaszuba, Jill Kolodsick, Fan Emily Yang, Margaret Gamalo, Dennis Brinker, Amy M. DeLozier, Jonathan Janes, Fabio P. Nunes, Jacob P. Thyssen, Eric L. Simpson - JAMA Dermatology 2020 cited by 279

  23. Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

    Authors: Andreas Wollenberg, Michael Howell, Emma Guttman‐Yassky, Jonathan I. Silverberg, Christopher Kell, Koustubh Ranade, Rachel Moate, René van der Merwe - Journal of Allergy and Clinical Immunology 2018 cited by 421

  24. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

    Authors: Eric L. Simpson, J.‐P. Lacour, Lynda Spelman, Ricardo Galimberti, Lawrence F. Eichenfield, Robert Bissonnette, Brett King, Jacob P. Thyssen, Jonathan I. Silverberg, Thomas Bieber, Kenji Kabashima, Yuichiro Tsunemi, Antonio Costanzo, Emma Guttman‐Yassky, Lisa A. Beck, Jonathan Janes, Amy M. DeLozier, Margaret Gamalo, Dennis Brinker, T. Cardillo, Fabio P. Nunes, Amy S. Paller, Andreas Wollenberg, Kristian Reich - British Journal of Dermatology 2020 cited by 379